Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1)-Reference-Cited by-同舟云学术

Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1)

Published:2016-11-28 Issue:12 Volume:68 Page:2901-2910
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Deodhar Atul A.¹,Dougados Maxime²,Baeten Dominique L.³,Cheng-Chung Wei James⁴,Geusens Piet⁵,Readie Aimee⁶,Richards Hanno B.⁷,Martin Ruvie⁶,Porter Brian⁶

Affiliation:

1. Oregon Health & Science University; Portland

2. Hôpital Cochin, Paris Descartes University; Paris France

3. University of Amsterdam; Amsterdam The Netherlands

4. Chung Shan Medical University; Taichung Taiwan

5. Maastricht University Hospital; Maastricht The Netherlands

6. Novartis Pharmaceuticals Corporation; East Hanover New Jersey

7. Novartis Pharma AG; Basel Switzerland

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference40 articles.

1. Axial spondyloarthritis criteria and modified NY criteria: issues and controversies;Deodhar;Clin Rheumatol,2014

2. The concept of spondyloarthritis: where are we now?;Garg;Best Pract Res Clin Rheumatol,2014

3. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway;Gran;Ann Rheum Dis,1985

4. Incidence and prevalence of ankylosing spondylitis in Finland;Kaipiainen-Seppanen;J Rheumatol,1997

5. Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002;Alamanos;Rheumatology,2004

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical performance of the ASAS health index in chinese patients with ankylosing spondylitis and its influencing factors;Clinical Rheumatology;2024-07-08

2. Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2;RMD Open;2024-04

3. Long-term effects of netakimab on health-related quality of life, back pain and work productivity in patients with ankylosing spondylitis: results of the international, multicentre, randomized double-blind phase III clinical trial BCD-085-5/ASTERA;Modern Rheumatology Journal;2023-12-19

4. Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases;RMD Open;2023-12

5. Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis;RMD Open;2023-11